Name, image and likeness (NIL) deals have flooded college sports with hundreds of millions of dollars — but universities and team general managers have been operating with little formal oversight, ...

WASHINGTON, D.C. — When people around the world are asked to name the single biggest problem facing their country, the answer is not war, climate change or politics. Instead, it’s something closer to ...

Boeing just announced the end of years of deep financial losses, a turnaround for a company after nearly seven years of bad news. The US aircraft maker reported $8.2 billion in net profit in the ...

Baylor Basketball is off to a rough start in conference play and needs to turn its season around quickly. In order to do so, they'll need to start playing better against the best teams in the country.

For nine months, the TACO trade has proved a reliably winning one on Wall Street. Short for “Trump Always Chickens Out,” it emerged in the wake of the U.S. president’s global tariff rollout — and ...

BERLIN—The country on the front line of Europe’s rearmament effort is struggling to meet its military recruitment goals. The problem isn’t pacifism, but young people posing a new variation on the ...

Oil prices are retreating after a geopolitics-driven spike, as the glut narrative regains control. Rising inventories, sanctioned crude weighing on tanker data, and new Venezuelan barrels reinforce ...

Over the weekend, Neel Somani, who is a software engineer, former quant researcher, and a startup founder, was testing the math skills of OpenAI’s new model when he made an unexpected discovery. After ...

US President Donald Trump raised potential antitrust concerns around Netflix Inc.’s planned $72 billion acquisition of Warner Bros. Discovery Inc., noting that the market share of the combined entity ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...